This work addresses longstanding challenges in drug development, where traditional animal models often fail to predict human cardiac outcomes. Through a multi-year FDA-funded grant, the committee assessed the performance of new approach methodologies (NAMs), including human-induced pluripotent stem cell–derived ...
Validating and Using Cardiac NAMs for Toxicity Screening and Drug Development
International Journal of Toxicology, 2025

